Literature DB >> 8880942

Amphetamine self-administration by humans: modulation by contingencies associated with task performance.

S D Comer1, M Haney, R W Foltin, M W Fischman.   

Abstract

The effect of task performance feedback and associated monetary earnings on drug self-administration were evaluated using eight subjects in a residential laboratory setting. The hypothesis was that if subjects believed that d-amphetamine impaired performance and reduced monetary earnings, d-amphetamine self-administration would decrease. Subjects performed computer tasks every day: on certain days that they received capsules, subjects were given bogus feedback regarding their performance ("better" or "worse" than average). On sample days, subjects were required to take d-amphetamine (10 mg BID) or placebo (0 mg BID) capsules. On choice days, subjects could choose between either d-amphetamine or placebo. Subjects received feedback on their task performance on 2 sample days and 2 of 4 choice days. Subjects received no feedback on the remaining two choice days. When subjects received no feedback, they chose d-amphetamine over placebo 78% of the time, and when they were given better feedback messages, they chose d-amphetamine 87.5% of the time. In contrast, d-amphetamine self-administration decreased significantly to 25% when subjects were told that it impaired their performance on work tasks and resulted in reduced earnings. In reality, d-amphetamine had little effect on work task performance. However, compared to placebo, d-amphetamine significantly increased subjective ratings of "Stimulated" and "Good Drug Effect" and significantly decreased ratings of "Tired" and "Sleepy." These results demonstrate that d-amphetamine served as a reinforcer under conditions in which drug self-administration did not influence monetary earnings, but that d-amphetamine self-administration could be modified by feedback/monetary earnings. Thus, contingencies associated with performance have important implications for drug use in the workplace.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8880942     DOI: 10.1007/bf02805973

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  18 in total

1.  Parsing attentional components during a simple reaction time task using sleep deprivation and amphetamine intervention.

Authors:  J C Cochran; D R Thorne; D M Penetar; P A Newhouse
Journal:  Percept Mot Skills       Date:  1992-12

2.  The effects of repeated amphetamine exposure on multiple measures of human behavior.

Authors:  T H Kelly; R W Foltin; M W Fischman
Journal:  Pharmacol Biochem Behav       Date:  1991-02       Impact factor: 3.533

3.  Individual differences in the reinforcing and subjective effects of amphetamine and diazepam.

Authors:  H de Wit; E H Uhlenhuth; C E Johanson
Journal:  Drug Alcohol Depend       Date:  1986-02       Impact factor: 4.492

Review 4.  Drugs and sleep.

Authors:  I Oswald
Journal:  Pharmacol Rev       Date:  1968-12       Impact factor: 25.468

5.  Effect of amphetamine on human macronutrient intake.

Authors:  R W Foltin; T H Kelly; M W Fischman
Journal:  Physiol Behav       Date:  1995-11

6.  Modulation of drug reinforcement by behavioral requirements following drug ingestion.

Authors:  K Silverman; K C Kirby; R R Griffiths
Journal:  Psychopharmacology (Berl)       Date:  1994-03       Impact factor: 4.530

7.  Effects of smoking on rapid information processing performance.

Authors:  K Wesnes; D M Warburton
Journal:  Neuropsychobiology       Date:  1983       Impact factor: 2.328

8.  The effects of d-amphetamine on food intake of humans living in a residential laboratory.

Authors:  R W Foltin; T H Kelly; M W Fischman
Journal:  Appetite       Date:  1990-08       Impact factor: 3.868

9.  Differential effects of scopolamine and amphetamine on microcomputer-based performance tests.

Authors:  R S Kennedy; R C Odenheimer; D R Baltzley; W P Dunlap; C D Wood
Journal:  Aviat Space Environ Med       Date:  1990-07

10.  A comparison of assessment techniques measuring the effects of methylphenidate, secobarbital, diazepam and diphenhydramine in abstinent alcoholics.

Authors:  T P Miller; J L Taylor; J R Tinklenberg
Journal:  Neuropsychobiology       Date:  1988       Impact factor: 2.328

View more
  14 in total

1.  The reinforcing, subject-rated, performance, and cardiovascular effects of d-amphetamine: influence of sensation-seeking status.

Authors:  William W Stoops; Joshua A Lile; C Glenn Robbins; Catherine A Martin; Craig R Rush; Thomas H Kelly
Journal:  Addict Behav       Date:  2006-10-02       Impact factor: 3.913

2.  Relationship between oral D-amphetamine self-administration and ratings of subjective effects: do subjective-effects ratings correspond with a progressive-ratio measure of drug-taking behavior?

Authors:  B Levi Bolin; Anna R Reynolds; William W Stoops; Craig R Rush
Journal:  Behav Pharmacol       Date:  2013-09       Impact factor: 2.293

3.  A direct comparison of the behavioral and physiological effects of methamphetamine and 3,4-methylenedioxymethamphetamine (MDMA) in humans.

Authors:  Matthew G Kirkpatrick; Erik W Gunderson; Audrey Y Perez; Margaret Haney; Richard W Foltin; Carl L Hart
Journal:  Psychopharmacology (Berl)       Date:  2011-06-30       Impact factor: 4.530

4.  The acute effects of d-amphetamine and methamphetamine on attention and psychomotor performance.

Authors:  Beata Y Silber; Rodney J Croft; Katherine Papafotiou; Con Stough
Journal:  Psychopharmacology (Berl)       Date:  2006-06-08       Impact factor: 4.530

5.  The acetylcholinesterase inhibitor rivastigmine does not alter total choices for methamphetamine, but may reduce positive subjective effects, in a laboratory model of intravenous self-administration in human volunteers.

Authors:  R De La Garza; J J Mahoney; C Culbertson; S Shoptaw; T F Newton
Journal:  Pharmacol Biochem Behav       Date:  2008-01-22       Impact factor: 3.533

6.  Methamphetamine self-administration by humans subjected to abrupt shift and sleep schedule changes.

Authors:  Matthew G Kirkpatrick; Margaret Haney; Suzanne K Vosburg; Sandra D Comer; Richard W Foltin; Carl L Hart
Journal:  Psychopharmacology (Berl)       Date:  2008-12-04       Impact factor: 4.530

7.  Acute d-amphetamine pretreatment does not alter stimulant self-administration in humans.

Authors:  William W Stoops; Andrea R Vansickel; Joshua A Lile; Craig R Rush
Journal:  Pharmacol Biochem Behav       Date:  2007-04-05       Impact factor: 3.533

Review 8.  Reinforcing effects of stimulants in humans: sensitivity of progressive-ratio schedules.

Authors:  William W Stoops
Journal:  Exp Clin Psychopharmacol       Date:  2008-12       Impact factor: 3.157

9.  Acute physiological and behavioral effects of intranasal methamphetamine in humans.

Authors:  Carl L Hart; Erik W Gunderson; Audrey Perez; Matthew G Kirkpatrick; Andrew Thurmond; Sandra D Comer; Richard W Foltin
Journal:  Neuropsychopharmacology       Date:  2007-09-12       Impact factor: 7.853

10.  Effects of acute oral naltrexone on the subjective and physiological effects of oral D-amphetamine and smoked cocaine in cocaine abusers.

Authors:  Sandra D Comer; Shanthi Mogali; Phillip A Saccone; Paula Askalsky; Diana Martinez; Ellen A Walker; Jermaine D Jones; Suzanne K Vosburg; Ziva D Cooper; Perrine Roux; Maria A Sullivan; Jeanne M Manubay; Eric Rubin; Abigail Pines; Emily L Berkower; Margaret Haney; Richard W Foltin
Journal:  Neuropsychopharmacology       Date:  2013-06-05       Impact factor: 7.853

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.